Literature DB >> 16353908

Postexposure management and treatment of anthrax in dogs--executive councils of the American Academy of Veterinary Pharmacology and Therapeutics and the American College of Veterinary Clinical Pharmacology.

Cory Langston1.   

Abstract

Dogs are generally at low risk of developing disease following exposure to anthrax. When disease does occur, it appears associated with oral exposure to the bacteria leading to massive swelling of the head, neck, and mediastinal regions. Death is due to toxemia and shock. For animals at high risk, such as search and rescue dogs with a known exposure, doxycycline at 5 mg/kg orally once daily for 45 to 60 days is suggested as a prophylactic treatment. Additional information on the diagnosis, prevention, and treatment of the disease in dogs is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353908      PMCID: PMC2750964          DOI: 10.1208/aapsj070227

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  2 in total

1.  Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores.

Authors:  C A Gleiser; W S Gochenour; M K Ward
Journal:  J Comp Pathol       Date:  1968-10       Impact factor: 1.311

2.  Anthrax in a dog.

Authors:  E D McGee; D L Fritz; J W Ezzell; H L Newcomb; R J Brown; N K Jaax
Journal:  Vet Pathol       Date:  1994-07       Impact factor: 2.221

  2 in total
  2 in total

1.  Human anthrax outbreak associated with livestock exposure: Georgia, 2012.

Authors:  A Navdarashvili; T J Doker; M Geleishvili; D L Haberling; G A Kharod; T H Rush; E Maes; K Zakhashvili; P Imnadze; W A Bower; H T Walke; S V Shadomy
Journal:  Epidemiol Infect       Date:  2015-06-19       Impact factor: 4.434

2.  First PCR Confirmed anthrax outbreaks in Ethiopia-Amhara region, 2018-2019.

Authors:  Baye Ashenefe Wassie; Surafel Fantaw; Yonas Mekonene; Amete Mihret Teshale; Yohannis Yitagesu; Estifanos Tsige; Desalegn Getahun; Geremew Tasew; Getachew Abichu; Beyene Moges; Ebba Abate; Takele Abayneh; Taye Zeru; Zewdu Belay; Siobhan M Mor
Journal:  PLoS Negl Trop Dis       Date:  2022-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.